Pharmacokinetics of terbinafine after single oral dose administration in red-tailed hawks (Buteo jamaicensis)

Ursula Bechert, J. Mark Christensen, Robert H Poppenga, Sahar A. Fahmy, Patrick Redig

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

To determine pharmacokinetic parameters of orally administered terbinafine hydrochloride for potential treatment of aspergillosis in raptors, 10 adult red-tailed hawks (Buteo jamaicensis) were used in single dose trials by using 15, 30, and 60 mg/kg doses with a 2-week washout period between trials. After administration of 15 mg/kg terbinafine, mean (± SD) plasma concentration peaked in approximately 5 hours at 0.3 ± 0.24 μg/mL, whereas a 30 mg/kg dose resulted in peak mean (± SD) plasma concentration of 1.2 ± 0.40 μg/mL in 3 hours and a 60 mg/kg dose resulted in mean (± SD) concentration of 2.0 ± 0.75 μg/mL in 5 hours. The volume of distribution decreased with increasing doses, averaging 76.8 ± 38.06 mL/kg for the 15 mg/kg dose and falling to 55.2 ± 17.4 mL/kg for the 30 mg/kg dose. This suggests that terbinafine accumulated in deep tissues, limiting further distribution at higher doses. The harmonic mean (± SD) half-life was biphasic, with initial values of 14.7 ± 6.67 hours, 17.5 ± 8.7 hours, and 13.3 ± 5.03 hours for 15, 30, and 60 mg/kg doses, respectively. A rapid first-elimination phase was followed by a slower second phase, and final elimination was estimated to be 161 ± 78.2 and 147 ± 65.6 hours for 15 and 30 mg/kg doses, respectively. Linearity was demonstrated for the area under the curve but not for peak plasma concentrations for the 3 doses used. Calculations based on pharmacokinetic parameter values indicated that a dosage of 22 mg/kg terbinafine q24h would result in steady-state trough plasma concentrations above the minimum inhibitory concentration of terbinafine (0.8-1.6 μg/mL). This dosage is recommended as a potential treatment option for aspergillosis in raptors. However, additional research is required to determine both treatment efficacy and safety.

Original languageEnglish (US)
Pages (from-to)122-130
Number of pages9
JournalJournal of Avian Medicine and Surgery
Volume24
Issue number2
DOIs
StatePublished - Jun 2010

Fingerprint

terbinafine
Hawks
Buteo jamaicensis
pharmacokinetics
Oral Administration
mouth
Pharmacokinetics
Raptors
dosage
Aspergillosis
Microbial Sensitivity Tests
Area Under Curve
aspergillosis
Half-Life
birds of prey
Safety

Keywords

  • aspergillosis
  • Aspergillus flavius
  • Aspergillus fumigatus
  • avian
  • Buteo jamaicensis
  • raptors
  • red-tailed hawks
  • terbinafine

ASJC Scopus subject areas

  • Small Animals
  • Medicine(all)

Cite this

Pharmacokinetics of terbinafine after single oral dose administration in red-tailed hawks (Buteo jamaicensis). / Bechert, Ursula; Christensen, J. Mark; Poppenga, Robert H; Fahmy, Sahar A.; Redig, Patrick.

In: Journal of Avian Medicine and Surgery, Vol. 24, No. 2, 06.2010, p. 122-130.

Research output: Contribution to journalArticle

Bechert, Ursula ; Christensen, J. Mark ; Poppenga, Robert H ; Fahmy, Sahar A. ; Redig, Patrick. / Pharmacokinetics of terbinafine after single oral dose administration in red-tailed hawks (Buteo jamaicensis). In: Journal of Avian Medicine and Surgery. 2010 ; Vol. 24, No. 2. pp. 122-130.
@article{6fe9f53af5d64ad9943303f3ff7fb6cf,
title = "Pharmacokinetics of terbinafine after single oral dose administration in red-tailed hawks (Buteo jamaicensis)",
abstract = "To determine pharmacokinetic parameters of orally administered terbinafine hydrochloride for potential treatment of aspergillosis in raptors, 10 adult red-tailed hawks (Buteo jamaicensis) were used in single dose trials by using 15, 30, and 60 mg/kg doses with a 2-week washout period between trials. After administration of 15 mg/kg terbinafine, mean (± SD) plasma concentration peaked in approximately 5 hours at 0.3 ± 0.24 μg/mL, whereas a 30 mg/kg dose resulted in peak mean (± SD) plasma concentration of 1.2 ± 0.40 μg/mL in 3 hours and a 60 mg/kg dose resulted in mean (± SD) concentration of 2.0 ± 0.75 μg/mL in 5 hours. The volume of distribution decreased with increasing doses, averaging 76.8 ± 38.06 mL/kg for the 15 mg/kg dose and falling to 55.2 ± 17.4 mL/kg for the 30 mg/kg dose. This suggests that terbinafine accumulated in deep tissues, limiting further distribution at higher doses. The harmonic mean (± SD) half-life was biphasic, with initial values of 14.7 ± 6.67 hours, 17.5 ± 8.7 hours, and 13.3 ± 5.03 hours for 15, 30, and 60 mg/kg doses, respectively. A rapid first-elimination phase was followed by a slower second phase, and final elimination was estimated to be 161 ± 78.2 and 147 ± 65.6 hours for 15 and 30 mg/kg doses, respectively. Linearity was demonstrated for the area under the curve but not for peak plasma concentrations for the 3 doses used. Calculations based on pharmacokinetic parameter values indicated that a dosage of 22 mg/kg terbinafine q24h would result in steady-state trough plasma concentrations above the minimum inhibitory concentration of terbinafine (0.8-1.6 μg/mL). This dosage is recommended as a potential treatment option for aspergillosis in raptors. However, additional research is required to determine both treatment efficacy and safety.",
keywords = "aspergillosis, Aspergillus flavius, Aspergillus fumigatus, avian, Buteo jamaicensis, raptors, red-tailed hawks, terbinafine",
author = "Ursula Bechert and Christensen, {J. Mark} and Poppenga, {Robert H} and Fahmy, {Sahar A.} and Patrick Redig",
year = "2010",
month = "6",
doi = "10.1647/2008-052.1",
language = "English (US)",
volume = "24",
pages = "122--130",
journal = "Journal of Avian Medicine and Surgery",
issn = "1082-6742",
publisher = "Association of Avian Veterinarians",
number = "2",

}

TY - JOUR

T1 - Pharmacokinetics of terbinafine after single oral dose administration in red-tailed hawks (Buteo jamaicensis)

AU - Bechert, Ursula

AU - Christensen, J. Mark

AU - Poppenga, Robert H

AU - Fahmy, Sahar A.

AU - Redig, Patrick

PY - 2010/6

Y1 - 2010/6

N2 - To determine pharmacokinetic parameters of orally administered terbinafine hydrochloride for potential treatment of aspergillosis in raptors, 10 adult red-tailed hawks (Buteo jamaicensis) were used in single dose trials by using 15, 30, and 60 mg/kg doses with a 2-week washout period between trials. After administration of 15 mg/kg terbinafine, mean (± SD) plasma concentration peaked in approximately 5 hours at 0.3 ± 0.24 μg/mL, whereas a 30 mg/kg dose resulted in peak mean (± SD) plasma concentration of 1.2 ± 0.40 μg/mL in 3 hours and a 60 mg/kg dose resulted in mean (± SD) concentration of 2.0 ± 0.75 μg/mL in 5 hours. The volume of distribution decreased with increasing doses, averaging 76.8 ± 38.06 mL/kg for the 15 mg/kg dose and falling to 55.2 ± 17.4 mL/kg for the 30 mg/kg dose. This suggests that terbinafine accumulated in deep tissues, limiting further distribution at higher doses. The harmonic mean (± SD) half-life was biphasic, with initial values of 14.7 ± 6.67 hours, 17.5 ± 8.7 hours, and 13.3 ± 5.03 hours for 15, 30, and 60 mg/kg doses, respectively. A rapid first-elimination phase was followed by a slower second phase, and final elimination was estimated to be 161 ± 78.2 and 147 ± 65.6 hours for 15 and 30 mg/kg doses, respectively. Linearity was demonstrated for the area under the curve but not for peak plasma concentrations for the 3 doses used. Calculations based on pharmacokinetic parameter values indicated that a dosage of 22 mg/kg terbinafine q24h would result in steady-state trough plasma concentrations above the minimum inhibitory concentration of terbinafine (0.8-1.6 μg/mL). This dosage is recommended as a potential treatment option for aspergillosis in raptors. However, additional research is required to determine both treatment efficacy and safety.

AB - To determine pharmacokinetic parameters of orally administered terbinafine hydrochloride for potential treatment of aspergillosis in raptors, 10 adult red-tailed hawks (Buteo jamaicensis) were used in single dose trials by using 15, 30, and 60 mg/kg doses with a 2-week washout period between trials. After administration of 15 mg/kg terbinafine, mean (± SD) plasma concentration peaked in approximately 5 hours at 0.3 ± 0.24 μg/mL, whereas a 30 mg/kg dose resulted in peak mean (± SD) plasma concentration of 1.2 ± 0.40 μg/mL in 3 hours and a 60 mg/kg dose resulted in mean (± SD) concentration of 2.0 ± 0.75 μg/mL in 5 hours. The volume of distribution decreased with increasing doses, averaging 76.8 ± 38.06 mL/kg for the 15 mg/kg dose and falling to 55.2 ± 17.4 mL/kg for the 30 mg/kg dose. This suggests that terbinafine accumulated in deep tissues, limiting further distribution at higher doses. The harmonic mean (± SD) half-life was biphasic, with initial values of 14.7 ± 6.67 hours, 17.5 ± 8.7 hours, and 13.3 ± 5.03 hours for 15, 30, and 60 mg/kg doses, respectively. A rapid first-elimination phase was followed by a slower second phase, and final elimination was estimated to be 161 ± 78.2 and 147 ± 65.6 hours for 15 and 30 mg/kg doses, respectively. Linearity was demonstrated for the area under the curve but not for peak plasma concentrations for the 3 doses used. Calculations based on pharmacokinetic parameter values indicated that a dosage of 22 mg/kg terbinafine q24h would result in steady-state trough plasma concentrations above the minimum inhibitory concentration of terbinafine (0.8-1.6 μg/mL). This dosage is recommended as a potential treatment option for aspergillosis in raptors. However, additional research is required to determine both treatment efficacy and safety.

KW - aspergillosis

KW - Aspergillus flavius

KW - Aspergillus fumigatus

KW - avian

KW - Buteo jamaicensis

KW - raptors

KW - red-tailed hawks

KW - terbinafine

UR - http://www.scopus.com/inward/record.url?scp=77953592346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953592346&partnerID=8YFLogxK

U2 - 10.1647/2008-052.1

DO - 10.1647/2008-052.1

M3 - Article

C2 - 20806657

AN - SCOPUS:77953592346

VL - 24

SP - 122

EP - 130

JO - Journal of Avian Medicine and Surgery

JF - Journal of Avian Medicine and Surgery

SN - 1082-6742

IS - 2

ER -